Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
RiverNorth RIV Stock Price Target RiverNorth posts 163 EPS on solid 363T revenue Simon Property Group Inc SPG Retains Top Position in Smead Value Fund Amid Q1 2026 Portfolio Restructuring PMN ProMIS Q4 2025 earnings trail estimates by 334 shares drop 074 on zero quarterly revenue Alto Neuro ANRO Stock Volume Deceleration Surges 20260422 Eaton EVF Stock Why It Could Accumulate Quiet 20260420 The numbers behind Senti Biosciences SNTI stock nobody talks about Market Focus 20260506 EXFY Expensify posts Q4 2025 loss against consensus profit estimates shares dip 09 today Global X FinTech ETF FINX YTD Underperformance Highlights Diverging Dynamics Across Digital Economy Thematic ETFs Amid Rate Volatility Is Top Wealth TWG stock worth allocating capital to Intelligent IPM Q1 2026 Results Fall Short EPS 004 Revenue NA DistNow DNOW Stalls at 1302 Breakout or Breakdown 20260519 BLK Tax Muni BBN Trading at 1603 Key Decision Point 20260514 FS Bancorp FSBW Slips 125 Testing 3762 Support 20260517 lululemon LULU Delivers Q1 2026 Beat EPS 501 vs 488 Expected Vertiv Deepens AI Data Center Focus with Expanded Power and Cooling Solutions Praetorian Acquisition Corp Warrant PTORW Surges 9 as Price Tests Key Resistance at 036 Standard BioTools LAB Q1 2026 Earnings Surprise EPS 033 Up Significant AutoNation AN Q1 2026 Earnings EPS Beats Estimates Stock Gains on Resilient Margin Performance VOC Energy Trust Q3 2024 Earnings Stable Distribution Amid Flat Trust Unit Performance ORLA Q1 2026 Earnings Slight EPS Miss Amid Operational Adjustments Bowhead Specialty Holdings Inc Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline First Citizens BancShares FCNCP Q1 2026 Earnings EPS Beats Estimates by Double Digits Shares Edge Higher Electromed Inc ELMD Holds Steady Near Resistance as Market Weighs Momentum Graham Corporation GHM Gains 253 as Shares Test Key Resistance at 9971 Cellectis CLLS Stock Dips 127 as Biotech Volatility Persists Key Support at 332 in Focus First Bank FRBA Slips 08 as NearTerm Resistance Holds